According to a ground-breaking discovery, the neuro immunoassays industry size is poised to completely alter the diagnostics landscape. With a projected valuation of US$5,303.1 million by 2033 (compared to US$2,616.1 million in 2023), this market is expected to grow at a remarkable 7.3% CAGR throughout the course of the forecast period. Navigating the forefront of …